Navigation Links
Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
Date:9/17/2007

MirixaPro 2.2 enables the next generation in medication therapy management

and medication adherence services

RESTON, Va., Sept. 17 /PRNewswire/ -- Mirixa Corporation, a leading developer of innovative clinical solutions that facilitate pharmacist-based patient care services, today announced the immediate availability of version 2.2 of the MirixaPro(TM) product suite (MirixaPro 2.2). With this latest release of MirixaPro, pharmacies nationwide have fingertip access to an enhanced array of clinical care management tools that streamline pharmacy-based delivery of targeted patient care services including medication therapy management (MTM), medication adherence and disease management.

Leveraging Mirixa's technology, pharmacists have delivered tens of thousands of targeted MTM patient interventions, resolved thousands of alerts indicating potential safety issues and worked actively with patients and physicians to improve medication-related care. Qualifying patient cases are delivered directly and securely to the pharmacist, along with the patient's medication history. MirixaPro's workflow system supports delivery of multiple interventions through a single Web-based interface.

"Medication non-adherence and inadequate medication management is nothing short of a national epidemic," says Eric Zimmerman, Chief Innovation Officer and General Manager of Mirixa Clinical. "About 50% of patients with chronic conditions do not take their medications correctly -- we can and must do far better. At Mirixa, we're convinced the solution starts by levering the 'triangle of trust' between patients, physicians and pharmacists.

"MirixaPro makes collaboration easier by using data to pinpoint care improvement opportunities, monitor progress, and speed the flow of information across a secure network of care. The results so far are encouraging -- every day we hear from pharmacists using our technologies to collaborate with physicians to close gaps in care, resolve safety risks, and help consumers become confident and successful in managing their health," added Zimmerman.

MirixaPro 2.2 will be previewed by industry leaders at the Health 2.0 Conference on September 20 in San Francisco, CA as well as at the NACDS Medication Therapy Management Services in Community Pharmacy Conference September 19-20 in Philadelphia, PA.

About Mirixa

Mirixa Corporation is a leading developer of innovative clinical solutions that facilitate pharmacist-based patient care services and a leader in Medication Therapy Management (MTM) technology solutions. Founded by the National Community Pharmacists Association (NCPA), Mirixa has assembled the largest pharmacy services network of its kind with over 40,000 contracted community pharmacies -- including both independents and chains. Mirixa's technology portfolio empowers the delivery of highly targeted medication management programs, patient education, recruitment campaigns and patient medication records. The company's leadership team shares a vision and passion for improving patient care, reducing overall health costs, and expanding consumer access to accurate medication information. Mirixa is headquartered in the heart of the Dulles Technology Corridor in Reston, VA; with offices in California, Texas and New Jersey. For more information visit http://www.Mirixa.com.

Contact: Liz Deakin

Mirixa Corporation

Phone: 703-600-1226

E-mail: ldeakin@mirixa.com


'/>"/>
SOURCE Mirixa Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 2016 , ... There are many ways to cook a hot dog, but ... Americans prefer their dogs straight off the grill. Of the 90 percent of Americans ... to cook a hot dog, far outpacing other cooking methods such as steaming (12 ...
(Date:5/26/2016)... ... May 26, 2016 , ... Intalere, the healthcare ... suppliers for its inaugural Member Conference at the Paris Hotel in Las Vegas, ... operational health of America’s healthcare providers. , The conference was highlighted by the ...
(Date:5/26/2016)... ... , ... On Memorial Day, Hope For Heroes and USA Medical ... for the country. The nonprofit Hope For Heroes partnered with the leading provider ... for disabled military veterans, as well as police, firemen, and EMS professionals across the ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are nearly 14.5 million people living ... survivors worldwide. On Sunday, June 5, 2016, communities around the world will gather to ... , National Cancer Survivors Day® is an annual worldwide Celebration of Life that ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel ... Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale ... of Retina Group of New York , is a Board Certified ophthalmologist ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 26, 2016   Change Healthcare , ... network solutions and technology-enabled services designed to ... into a strategic channel partnership with SourceMed, ... solutions and revenue cycle management services that ... rehabilitation clinics to optimize revenue, operational efficiency ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
Breaking Medicine Technology: